# nLIGHT

Type: Company (LASR)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/nlight
Canonical HTML page: https://getfinancebrief.com/entity/nlight

## Timeline

- **2026-08-14**: MP Materials and Maravai Q2 2026 transcripts released — Call transcripts were published for the rare-earth and life-science companies.
- **2026-08-13**: Acacia Research Q2 2026 Earnings Call — Record $114.6M revenue from IP licensing settlement; Life Sciences write-down disclosed.
- **2026-08-13**: Dutch Bros Q2 2026 Earnings Call — Revenue grew 32.5% year over year on shop expansion and accelerating same-store sales.
- **2026-08-13**: Datadog Q2 2026 Earnings Call — CEO Olivier Pomel and CFO David Obstler discussed product capabilities and market opportunities.

## Recent coverage (4 stories)

### Acacia's Record $114.6M Q2 Revenue, Dutch Bros +32.5% Top Earnings
2026-08-14 13:07:44 · Sentiment: Bullish · Impact: 6/10 · Sources: 3

Q2 2026 earnings show Acacia Research's record $114.6M IP-settlement revenue countered by a Life Sciences write-down, while Dutch Bros grew 32.5%. Datadog, MP Materials, and Maravai add cloud, rare-earth, and biotech signals for investors.
Full story: https://getfinancebrief.com/story/acacia-actg-record-114m-ip-settlement-dutch-bros-32-5-pct-q2-2026

### nLIGHT Profitability Surges Following Strategic Exit from Industrial Laser Segment
2026-03-17 16:34:40 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

nLIGHT (LASR) has reported a significant improvement in profitability following its strategic decision to exit the commodity industrial fiber laser market. The company is successfully pivoting toward high-margin Aerospace, Defense, and Additive Manufacturing sectors, driving shares toward recent highs.
Full story: https://getfinancebrief.com/story/nlight-lasr-profitability-industrial-laser-exit

### Post-Earnings Volatility Hits agilon health and nLIGHT Amid Sector Pressures
2026-03-12 20:11:18 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Shares of agilon health (AGL) and nLIGHT (LASR) faced significant downward pressure on March 12, 2026, as investors reassessed valuation following recent earnings reports and insider activity. While agilon struggles with persistent medical cost trends, nLIGHT is navigating executive share sales and institutional exits.
Full story: https://getfinancebrief.com/story/agilon-health-nlight-stock-drop-analysis

### Q4 2025 Earnings Intelligence: SaaS Pivots and Tariff Resilience Define Results
2026-02-27 00:15:05 · Sentiment: Bullish · Impact: 7/10 · Sources: 19

A massive wave of Q4 2025 earnings reports reveals a corporate landscape aggressively pivoting toward recurring revenue models while navigating significant tariff and inflationary headwinds. Key performers in FinTech, SaaS, and Defense are demonstrating strong operating leverage despite localized consumer softness.
Full story: https://getfinancebrief.com/story/q4-2025-earnings-intelligence-briefing

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.